Stanford medicine chair to present 'Cardiovascular Clinical Research in the U.S.: Realities, Challenges and Opportunities'

22nd Annual Leonard Leight Lecture set for Sept. 30
Stanford medicine chair to present 'Cardiovascular Clinical Research in the U.S.: Realities, Challenges and Opportunities'

Robert Harrington, M.D.

Robert Harrington, M.D., chair and Arthur L. Bloomfield Professor of Medicine at Stanford University School of Medicine, will deliver the 22nd Annual Leonard Leight Lecture at the University of Louisville. The address will be held at noon, Wednesday, Sept. 30, at the Jewish Hospital Rudd Heart and Lung Center Conference Center, 16th Floor, 201 Abraham Flexner Way.

Harrington will present “Cardiovascular Clinical Research in the U.S.: Realities, Challenges and Opportunities.” Admission is free and continuing medical and nursing education credit is available. For details, contact 852-1162.

The Leonard Leight Lecture is presented annually by the Division of Cardiovascular Medicine in the Department of Medicine at the University of Louisville School of Medicine. For 30 years until 1996, Leight was a practicing cardiologist in Louisville and played a major role in developing cardiology services and bringing innovative treatment modalities in heart disease to Louisville. The Leonard Leight Lecture series was established in 1994 and is made possible by gifts from Dr. and Mrs. Kurt Ackermann and Medical Center Cardiologists to the Jewish Hospital & St. Mary’s Foundation.

Harrington is an interventional cardiologist and experienced clinical investigator in the area of heart disease. At Stanford, he leads a department of 220 faculty members in 14 divisions.

Prior to joining the Stanford faculty, Harrington spent five years as the director of the Duke Clinical Research Institute, regarded as the world’s largest academic clinical research organization. The institute has conducted studies in 65 countries while building diverse research programs in clinical trials and health services research. He joined the faculty at Duke in 1993.

As a clinical investigator, he has worked primarily in the area of acute ischemic heart disease, or heart disease resulting from restricted blood flow to the heart muscle. He has established clinical research collaborations that involve investigators from around the world.